As a leader who has committed much of his career to improving healthcare — an industry that holds millions of people’s lives ...

While employers are prioritizing mental and physical wellbeing programs, employees report that what they really want is financial wellbeing support, according to a new survey. The survey was ...

Over the past few years, the metabolic health space has been buzzing due to a mix of increasing awareness, novel drugs and personalized health tools. One of the most impactful developments in ...

Make no mistake: the hype surrounding generative AI in the healthcare sector is still going strong. Overall, the industry is excited about the technology’s potential to alleviate burnout ...

In a recent interview, Elizabeth Mitchell, president and CEO of the Purchaser Business Group on Health, discussed employers' ...

Novo Nordisk was a pioneer in developing GLP-1 drugs for metabolic disorders, but its products are still mainly once-weekly injections. The Danish pharmaceutical giant is putting up $285 million ...

Burnout among clinicians and staff remains a significant issue in healthcare, with widespread implications for patient care, staff retention, and the financial health of healthcare organizations.

Beam Therapeutics’ experimental gene-editing therapy for sickle cell disease now has its first cut of patient data showing signs of treating the rare blood disorder in a way that could ...

There’s no escaping AI – try as we all did at HLTH – but Brook Health’s plan is to use AI to extend the primary care provider’s relationship to the patient’s home for chronic disease ...